Antioxidant action of 7,8-dihydroxyflavone protects PC12 cells against 6-hydroxydopamine-induced cytotoxicity
- 1 January 2014
- journal article
- Published by Elsevier BV in Neurochemistry International
- Vol. 64, 18-23
- https://doi.org/10.1016/j.neuint.2013.10.018
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China to Z. Qu (81070215)
- L. Chen (31070942)
- Shandong Province Natural Science Foundation (ZR2010CM066)
- Shandong province higher education science and technology program (J10LC16)
This publication has 28 references indexed in Scilit:
- Protective Effect of Tetrahydroxystilbene Glucoside on 6-OHDA-Induced Apoptosis in PC12 Cells through the ROS-NO PathwayPLOS ONE, 2011
- 7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's DiseaseNeuropsychopharmacology, 2011
- Focus on histone variant H2AX: To be or not to beFEBS Letters, 2010
- A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavoneProceedings of the National Academy of Sciences of the United States of America, 2010
- Flavonoids and brain health: multiple effects underpinned by common mechanismsGenes & Nutrition, 2009
- Rho Kinase Inhibitor Y-27632 Down-Regulates Norepinephrine Synthesis and Release in PC12 CellsBasic & Clinical Pharmacology & Toxicology, 2009
- Oxidative stress and neurodegeneration: where are we now?Journal of Neurochemistry, 2006
- Regulation of Cu/Zn-Superoxide Dismutase Expression via the Phosphatidylinositol 3 Kinase/Akt Pathway and Nuclear Factor-κBJournal of Neuroscience, 2004
- Dopamine, 6-hydroxydopamine, iron, and dioxygen — their mutual interactions and possible implication in the development of Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1996
- Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in manJournal of Neural Transmission, 1996